{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:07:58Z","timestamp":1785946078320,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sheba MSC research","award":["1171"],"award-info":[{"award-number":["1171"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.autrev.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T14:01:29Z","timestamp":1539266489000},"page":"1235-1239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polymerase-1 pathway activation in acute multiple sclerosis relapse"],"prefix":"10.1016","volume":"17","author":[{"given":"Anat","family":"Achiron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Zilkha-Falb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bovim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onn","family":"Rozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Sarova-Pinhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Magalashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Menascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.07.006_bb0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.2.5861.292","article-title":"Multiple sclerosis: a review","volume":"2","author":"McAlpine","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2018.07.006_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.24682","article-title":"Predictors of long-term disability accrual in relapse-onset multiple sclerosis","volume":"80","author":"Jokubaitis","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.07.006_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/103.2.281","article-title":"Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients","volume":"103","author":"Confavreux","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.07.006_bb0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/brain\/112.6.1419","article-title":"The natural history of multiple sclerosis: a geographical based study. II. Predictive value of the early clinical course","volume":"112","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.07.006_bb0025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","volume":"126","author":"Confavreux","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.07.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158978","article-title":"Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study","volume":"11","author":"Bsteh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.07.006_bb0035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.autrev.2017.07.004","article-title":"Spasticity in multiple sclerosis: contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions","volume":"16","author":"Patejdl","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.07.006_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/WNL.0000000000001856","article-title":"Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis","volume":"85","author":"Novotna","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.07.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046871","article-title":"Suppressed RNA-polymerase-1 pathway is associated with benign multiple sclerosis","volume":"7","author":"Achiron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.07.006_bb0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12017-017-8456-8","article-title":"Experimental autoimmune encephalomyelitis ameliorated by passive transfer of polymerase 1-silenced MOG35-55 lymphatic node cells: verification of a novel therapeutic approach in multiple sclerosis","volume":"19","author":"Zilkha-Falb","year":"2017","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.autrev.2018.07.006_bb0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.07.006_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clineuro.2005.11.018","article-title":"Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment","volume":"108","author":"Confavreux","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2018.07.006_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.07.006_bb0070","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.07.006_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tibs.2004.12.008","article-title":"RNA-polymerase-I-directed rDNA transcription, life and works","volume":"30","author":"Russell","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.autrev.2018.07.006_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.pharmtox.010909.105844","article-title":"The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer","volume":"50","author":"Drygin","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.autrev.2018.07.006_bb0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00412-013-0430-0","article-title":"The nucleolus-guardian of cellular homeostasis and genome integrity","volume":"122","author":"Grummt","year":"2013","journal-title":"Chromosoma"},{"key":"10.1016\/j.autrev.2018.07.006_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000382130","article-title":"Multiple sclerosis relapses: epidemiology, outcomes and management. A systematic review","volume":"44","author":"Kalincik","year":"2015","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.autrev.2018.07.006_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.autrev.2017.11.019","article-title":"Combined therapies to treat complex diseases: the role of the gut microbiota in multiple sclerosis","volume":"17","author":"Calvo-Barreiro","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.07.006_bb0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/JNN.0000000000000252","article-title":"The emerging role of the gut microbiome in adult patients with multiple sclerosis","volume":"48","author":"Newland","year":"2016","journal-title":"J Neurosci Nurs"},{"key":"10.1016\/j.autrev.2018.07.006_bb0110","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.autrev.2013.02.006","article-title":"Effect of stress on brain inflammation and multiple sclerosis","volume":"12","author":"Karagkouni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.07.006_bb0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.07.006_bb0120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.autrev.2016.03.006","article-title":"Therapeutic strategies targeting B-cells in multiple sclerosis","volume":"15","author":"Milo","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.07.006_bb0125","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.30314","article-title":"The anti-CD20 antibody rituximab reduces the Th17 cell response","volume":"63","author":"van de Veerdonk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.07.006_bb0130","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1167\/iovs.14-15408","article-title":"The role of B cells in the early onset of the first demyelinating event of acute optic neuritis","volume":"56","author":"Feldman","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2018.07.006_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.40.2.229","article-title":"Heterogeneity of blood\u2013brain barrier changes in multiple sclerosis: an MRI study with gadolinium\u2013DTPA enhancement","volume":"40","author":"Kermode","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.07.006_bb0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/brain\/111.4.927","article-title":"Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis","volume":"111","author":"Miller","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.07.006_bb0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2017.04.010","article-title":"Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: a systematic review","volume":"16","author":"Merkel","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.07.006_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/1744666X.2017.1297232","article-title":"Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis","volume":"13","author":"Collins","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2018.07.006_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0404.2009.01213.x","article-title":"Corticosteroids in the treatment of multiple sclerosis","volume":"189","author":"Myhr","year":"2009","journal-title":"Acta Neurol Scand Suppl"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:13:48Z","timestamp":1761599628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1568997218302428"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.07.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymerase-1 pathway activation in acute multiple sclerosis relapse","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}